Northern Therapeutics Inc. is a private Canadian biopharmaceutical company committed to the discovery and development of novel cell and gene therapies to extend and enhance the quality of life for people suffering from chronic life-threatening pulmonary disorders as well as acute illness, in the absence of toxicity and major side effects.

Initiate, support, or direct the implementation of strategic planning for early stage cell and gene therapy products, including manufacturing and clinical development plans.

Research interests focus on the use of stem cells for the treatment of septic shock and COVID-19.